510(k) Report

510(k) · Cleared

Cleared

Mardx Lyme Disease (Igm) Marblot Strip Test System

K951709510(k) TraditionalCleared Jun 7, 1996421-day reviewClass II21 CFR 866.3830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mardx Diagnostics, Inc. · LSR Reagent, Borrelia Serological Reagent

Cleared on Jun 7, 1996 after a 421-day review. The FDA summary names no predicate by number. 5 later devices descend from it.

Decided
Jun 7, 1996
Review
421 days
Class
Class II
Product code
LSR
Recalls
None
Predicates
0

5 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2012: 1 descendant cleared2017: 1 descendant cleared1999: 1 descendant cleared2021: 2 descendants clearedReference device: K894293 · Mardx Lyme Disease Eia (Igm) Test System · Mardx Diagnostics, Inc. · 19891995200020052010201520202025
  1. This deviceK951709 Mardx Lyme Disease (Igm) Marblot Strip Test SystemMardx Diagnostics, Inc. · 1996
  2. Descendant · cites it directly · 2 of its ownK113846 Borrelia Burgdorferi Igm Blot TestGold Standard Diagnostics · 2012
  3. Descendant · 2 generations on · 0 of its ownK203292 Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test KitGold Standard Diagnostics · 2021
  4. Descendant · 2 generations on · 0 of its ownK203295 Gold Standard Diagnostics Borrelia burgdorferi IgM ELISA Test KitGold Standard Diagnostics · 2021
  5. Descendant · cites it directly · 0 of its ownK172254 Lyme B. burgdorferi (IgM) MarStripe TestTrinity Biotech · 2017
  6. Descendant · cites it directly · 0 of its ownK980351 Bbi-Biotech Research Laboratories B. Burgdorferi Igm Western Blot KitBoston Biomedica, Inc. · 1999

Most influential descendants

Showing 5 of 5 · See all
  • K113846Borrelia Burgdorferi Igm Blot TestGold Standard Diagnostics · 2012 · cites it directly2descendants
  • K203292Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test KitGold Standard Diagnostics · 2021 · 2 generations on0descendants
  • K203295Gold Standard Diagnostics Borrelia burgdorferi IgM ELISA Test KitGold Standard Diagnostics · 2021 · 2 generations on0descendants
  • K172254Lyme B. burgdorferi (IgM) MarStripe TestTrinity Biotech · 2017 · cites it directly0descendants
  • K980351Bbi-Biotech Research Laboratories B. Burgdorferi Igm Western Blot KitBoston Biomedica, Inc. · 1999 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K951709Mardx Lyme Disease (Igm) Marblot Strip Test SystemMardx Diagnostics, Inc.1996—
+1K113846Borrelia Burgdorferi Igm Blot TestGold Standard Diagnostics2012—
+2K203292Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test KitGold Standard Diagnostics2021—
+2K203295Gold Standard Diagnostics Borrelia burgdorferi IgM ELISA Test KitGold Standard Diagnostics2021—
+1K172254Lyme B. burgdorferi (IgM) MarStripe TestTrinity Biotech2017—
+1K980351Bbi-Biotech Research Laboratories B. Burgdorferi Igm Western Blot KitBoston Biomedica, Inc.1999—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
201210
201710
202120
FIG. 1 — Lineage of K951709, 1996–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LSR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LSR device

  1. #1 K254295 Sofia Lyme FIA; Sofia 2 Campylobacter FIAscore 12.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (5)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113846Borrelia Burgdorferi Igm Blot TestGold Standard Diagnostics20122
K172254Lyme B. burgdorferi (IgM) MarStripe TestTrinity Biotech20170
K980351Bbi-Biotech Research Laboratories B. Burgdorferi Igm Western Blot KitBoston Biomedica, Inc.19990

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K113846 (Gold Standard Diagnostics, 2012) has gone furthest, with 2 descendants of its own.

How does its category compare?

All LSR devices

LSR Reagent, Borrelia Serological Reagent: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LSR

2in 2025

2007: 12008: 22009: 22010: 12012: 32013: 22015: 12016: 12017: 62018: 32019: 42020: 32021: 62022: 12023: 12024: 12025: 22026 (partial year): 1
2007high 6 (2017) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LSR

133in 2021

2012: 155 days median2017: 150 days median2018: 92 days median2019: 86 days median2020: 91 days median2021: 133 days median
2007high 155 (2012) · low 86 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LSR

1in 2025

2013: 12021: 22025: 1
2007high 2 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LSR

1in 2025

2008: 22011: 12014: 532015: 252016: 102017: 92018: 42019: 152020: 72021: 42022: 12023: 22025: 1
2007high 53 (2014) · low 0 (2007)2025

MAUDE reports naming product code LSR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—02
20092—00
20101—00
20110—01
2012315500
20132—10
20140—053
20151—025
20161—010
2017615009
201839204
2019486015
202039107
2021613324
20221—01
20231—02
20241—00
20252—11
20261—0—

What is it indicated for?

MarDx Lyme Disease (IgM) Marblot Strip Test System is a Western blot assay for the qualitative detection of human IgM antibody to B. burgdorferi. The MarDx Lyme Disease (IgM) Marblot Strip Test System is intended for use in testing human serum samples which have been found positive or equivocal using an EIA or IFA test procedure.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K951709: Mardx Lyme Disease (Igm) Marblot Strip Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K951709

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026